Vascular effects and safety of dalcetrapib in patients with or at risk of coronary heart disease: the dal-VESSEL randomized clinical trial
2012 ◽
Vol 33
(7)
◽
pp. 857-865
◽
Keyword(s):
At Risk
◽
Keyword(s):
Keyword(s):
2002 ◽
Vol 144
(4)
◽
pp. 678-686
◽
Keyword(s):
2019 ◽
Vol 12
(Suppl_1)
◽